|Day Low/High||88.50 / 90.44|
|52 Wk Low/High||78.95 / 116.49|
For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
It's a wonder to me how split this market really is.
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Shares of Quest Diagnostics were slightly higher Tuesday after announcing an investigation into a data breach by a third-party that affected the health records of 34,000 people.
The 64 year old Tillerson became CEO of the Texas based oil giant in 2004 and has a close business relationship with Russian President Vladimir Putin.
Quest Diagnostics CEO Stephen Rusckowski discusses the Affordable Care Act and what's next for his company.
Here's a window into what institutional investors may be doing and how to profit from that.
LH's $5.7B Covance takeover could be just what the doctor ordered.
Quest could be vulnerable to a deep correction, but a decline to next support around $60 seems like the path of least resistance.
Jim Cramer answers viewers’ Twitter (TWTR) questions from the floor of the New York Stock Exchange.
Selling covered calls and naked puts can reduce risk. (Updated)
Light volume precedes break for Memorial Day.
Major indices continue to show little movement as we approached the noon hour, although they have turned down in the last half hour. I can't recall such a flat week this year. Maybe everyone is already in the Hamptons and it is just the computers tr...
Here are healthcare stocks of all shares and sizes with strong charts.
Try this options play for the sometimes volatile Bio-Reference Laboratories.